Literature DB >> 7239125

Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.

R Viscidi, S Willey, J G Bartlett.   

Abstract

Stool specimens in various patient populations were examined to determine isolation rates of Clostridium difficile and the frequency with which this organism produces a cytopathic toxin in vitro. Clostridium difficile was isolated from 13 of 45 healthy neonates who had never received antimicrobials and the cytotoxin was detected in 12. With 23 healthy children aged 4 to 24 mo the organism was recovered from 2 children and the cytotoxin was detected in 1. Neither the organism nor the cytotoxin was found in specimens from healthy adults who denied antimicrobial usage during the prior 4 wk. Clostridium difficile was recovered from 12 of 56 adults receiving antimicrobials without diarrhea, but only one specimen yielded the cytotoxin. Both the cytotoxin and the organism were found in stools from most patients with antibiotic-associated colitis. Concentrations of Clostridium difficile, when present, were similar in all patient populations. Broth cultures of 165 isolates of Clostridium difficile showed all strains, but two produced the cytotoxin in vitro. However, the concentration of the toxin was substantially higher with strains recovered from patients with positive toxin assays. These observations indicate that neonates are often asymptomatic carriers of both Clostridium difficile and its cytotoxin. In adults, gastrointestinal symptoms correlated best with results of tissue culture assays and with toxigenic potential of the strains isolated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239125

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  101 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile.

Authors:  Shonna M McBride; Abraham L Sonenshein
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.

Authors:  S L Peach; S P Borriello; H Gaya; F E Barclay; A R Welch
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

Review 4.  Diagnosis of Clostridium difficile Infections in Children.

Authors:  Stella Antonara; Amy L Leber
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

5.  Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene.

Authors:  A A Franco; L M Mundy; M Trucksis; S Wu; J B Kaper; C L Sears
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Patients' experience and perception of hospital-treated Clostridium difficile infections: a qualitative study.

Authors:  Isabelle Guillemin; Alexia Marrel; Jérémy Lambert; Axelle Beriot-Mathiot; Carole Doucet; Odysseas Kazoglou; Christine Luxemburger; Camille Reygrobellet; Benoit Arnould
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 7.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  Diarrheal disease and DRGs.

Authors:  Peter H Gilligan
Journal:  Clin Microbiol Newsl       Date:  2004-01-22

9.  Clostridium difficile colitis.

Authors:  Judith L Trudel
Journal:  Clin Colon Rectal Surg       Date:  2007-02

10.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.